Literature DB >> 26711734

Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia.

Bas B van Rijn1, Hein W Bruinse2, Jan H Veerbeek2, Emiel D Post Uiterweer2, Steven V Koenen2, Johanna G van der Bom2, Ger T Rijkers2, Mark Roest2, Arie Franx2.   

Abstract

Preeclampsia is an inflammatory-mediated hypertensive disorder of pregnancy and seems to be an early indicator of increased cardiovascular risk, but mechanisms underlying this association are unclear. In this study, we identified levels of circulating inflammatory markers and dynamic changes in the systemic acute-phase response in 44 women with a history of severe early-onset preeclampsia, compared with 29 controls with only uneventful pregnancies at 1.5 to 3.5 years postpartum. Models used were in vivo seasonal influenza vaccination and in vitro whole-blood culture with T-cell stimulants and the toll-like receptor-4 ligand lipopolysaccharide. Outcome measures were C-reactive protein, interleukin-6 (IL-6), IL-18, fibrinogen, myeloperoxidase, and a panel of 13 cytokines representative of the innate and adaptive inflammatory response, in addition to established cardiovascular markers. The in vivo acute-phase response was higher for women with previous preeclampsia than that for controls without such a history, although only significant for C-reactive protein (P=0.04). Preeclampsia was associated with higher IL-1β (P<0.05) and IL-8 (P<0.01) responses to T-cell activation. Hierarchical clustering revealed 2 distinct inflammatory clusters associated with previous preeclampsia: an adaptive response cluster associated with increased C-reactive protein and IL-6 before and after vaccination, increased weight, and low high-density lipoprotein cholesterol; and a toll-like receptor-4 mediated the cluster associated with increased IL-18 before and after vaccination but not associated with other cardiovascular markers. Furthermore, we found interactions between previous preeclampsia, common TLR4 gene variants, and the IL-18 response to vaccination. In conclusion, preeclampsia is associated with alterations in the inflammatory response postpartum mostly independent of other established cardiovascular risk markers.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  acute-phase response; inflammation; preeclampsia; pregnancy; toll-like receptors; vaccination

Mesh:

Substances:

Year:  2015        PMID: 26711734     DOI: 10.1161/HYPERTENSIONAHA.115.06455

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Impact of Immune Deficiency on Remodeling of Maternal Resistance Vasculature 4 Weeks Postpartum in Mice.

Authors:  Elizabeth A Bonney; Ann Howard; Kendall Krebs; Kelly Begin; Kelsey Veilleux; Natalia I Gokina
Journal:  Reprod Sci       Date:  2017-01-19       Impact factor: 3.060

Review 2.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

Review 3.  Adverse pregnancy outcomes and future maternal cardiovascular disease.

Authors:  Alisse Hauspurg; Wendy Ying; Carl A Hubel; Erin D Michos; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2018-02-15       Impact factor: 2.882

Review 4.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

5.  Postpartum metabolic syndrome and high-sensitivity C-reactive protein after gestational hypertension and pre-eclampsia.

Authors:  Alfred O Osoti; Stephanie T Page; Barbra A Richardson; Brandon L Guthrie; John Kinuthia; Stephen J Polyak; Carey Farquhar
Journal:  Int J Gynaecol Obstet       Date:  2020-09-16       Impact factor: 3.561

6.  Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis.

Authors:  L Brouwers; A J van der Meiden-van Roest; C Savelkoul; T E Vogelvang; A T Lely; A Franx; B B van Rijn
Journal:  BJOG       Date:  2018-08-10       Impact factor: 6.531

Review 7.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

8.  Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia.

Authors:  Victoria A deMartelly; John Dreixler; Avery Tung; Ariel Mueller; Sarah Heimberger; Abid A Fazal; Heba Naseem; Roberto Lang; Eric Kruse; Megan Yamat; Joey P Granger; Bhavisha A Bakrania; Javier Rodriguez-Kovacs; Sarosh Rana; Sajid Shahul
Journal:  J Am Heart Assoc       Date:  2021-02-23       Impact factor: 5.501

Review 9.  Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk.

Authors:  Wendy Ying; Janet M Catov; Pamela Ouyang
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

10.  Association Between TLR4 Gene Polymorphisms and Risk of Preeclampsia: Systematic Review and Meta-Analysis.

Authors:  Manni Sun; Hui Jiang; Tao Meng; Peiyan Liu; Haiying Chen
Journal:  Med Sci Monit       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.